VBI Vaccines, Inc. (VBIV) Financials

VBIV Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 75.4 million 80.9 million
Dec. 31, 2023 87.0 million 79.4 million
Sept. 30, 2023 100.8 million 80.9 million
June 30, 2023 88.3 million 79.6 million

VBIV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -11.9 million 579000
Dec. 31, 2023 -11.5 million 1.5 million
Sept. 30, 2023 -8.1 million 1.5 million
June 30, 2023 -19.3 million 1.7 million

VBIV Net Income

No data available :(

VBIV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2024 12.6 million 1.1 million 1.1 million
Dec. 31, 2023 23.7 million 1.3 million 1.3 million
Sept. 30, 2023 35.5 million 1.4 million 2.4 million
June 30, 2023 20.8 million 49.6 million 2.7 million

VBIV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2024 23.9 million
Dec. 31, 2023 23.9 million
Sept. 30, 2023 21.2 million
June 30, 2023 8.6 million

VBIV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2024 151000 2.6 million 7.7 million 2.5 million
Dec. 31, 2023 159222 1.4 million 8.4 million -2.5 million
Sept. 30, 2023 113000 1.5 million 9.0 million -
June 30, 2023 50000 3.3 million 10.9 million -

VBIV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2024 1.2 million 2.7 million
Dec. 31, 2023 853000 3.4 million
Sept. 30, 2023 6.6 million 2.5 million
June 30, 2023 720000 3.5 million

VBIV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VBIV

Price: $0.07

52 week price:
0.02
1.35

Earnings Per Share: -3.54 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 314214

Ebitda: -32.9 million

Market Capitalization: 1.9 million

Links: